BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16739353)

  • 1. Phase II study of weekly paclitaxel for relapsed and refractory small cell lung cancer.
    Yamamoto N; Tsurutani J; Yoshimura N; Asai G; Moriyama A; Nakagawa K; Kudoh S; Takada M; Minato Y; Fukuoka M
    Anticancer Res; 2006; 26(1B):777-81. PubMed ID: 16739353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer.
    Mori K; Kamiyama Y; Kondo T; Kano Y; Kodama T
    Cancer Chemother Pharmacol; 2006 Jul; 58(1):86-90. PubMed ID: 16447041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary results of a phase I study of weekly paclitaxel infusion in patients with non-small cell lung cancer.
    Akerley W; Glantz M; Choy H
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):14-8. PubMed ID: 8941405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-escalation study of weekly 1-hour paclitaxel administration in patients with refractory cancer.
    Chang AY; Boros L; Asbury R; Hui L; Rubins J
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-69-S17-71. PubMed ID: 9374098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I/II trial of weekly paclitaxel in patients with advanced lung cancer.
    Akerley W
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):55-8. PubMed ID: 9007123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer.
    Fidias P; Supko JG; Martins R; Boral A; Carey R; Grossbard M; Shapiro G; Ostler P; Lucca J; Johnson BE; Skarin A; Lynch TJ
    Clin Cancer Res; 2001 Dec; 7(12):3942-9. PubMed ID: 11751486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pilot study-previously treated advanced non-small cell lung cancer].
    Shirahama S; Aritomi T; Takeo S; Ando K; Wakamatsu S; Kumagawa M; Ichinose I; Tamura K
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2133-7. PubMed ID: 15628758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement and impact of co-morbidity in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. A phase II study of weekly paclitaxel.
    Juan O; Albert A; Campos JM; Caranyana V; Muñoz J; Alberola V
    Acta Oncol; 2007; 46(3):367-73. PubMed ID: 17450473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-Hodgkin's lymphoma: a Wisconsin Oncology Network Study.
    Kahl BS; Bailey HH; Smith EP; Turman N; Smith J; Werndli J; Williams EC; Longo WL; Kim KM; McGovern J; Jumonville A
    Cancer Invest; 2005; 23(1):13-8. PubMed ID: 15779863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and therapeutic efficacy of weekly 1-h low-dose paclitaxel infusion for relapsed breast cancer.
    Kim R; Osaki A; Toge T
    Oncol Rep; 2003; 10(1):145-50. PubMed ID: 12469161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early phase II study of BMS-181339 (paclitaxel) in patients with non-small cell lung cancer. BMS-181339 Non-Small Cell Lung Cancer Study Group].
    Yoneda S; Nishiwaki Y; Niitani H; Kurita Y; Ariyoshi Y; Ikegami H; Furuse K; Fukuoka M; Kimura I; Hara N; Saijo N
    Gan To Kagaku Ryoho; 1996 May; 23(6):695-701. PubMed ID: 8645020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
    Charoentum C; Thongprasert S; Chewasakulyong B
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1603-7. PubMed ID: 17940374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Weekly paclitaxel therapy for metastatic breast cancer].
    Kokufu I; Taniguchi H; Kimura F; Fukuda K; Yamamoto M; Yano T; Yamada K
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):221-6. PubMed ID: 11865627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in Japan.
    Horiguchi J; Rai Y; Tamura K; Taki T; Hisamatsu K; Ito Y; Seriu T; Tajima T
    Anticancer Res; 2009 Feb; 29(2):625-30. PubMed ID: 19331212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.
    Rossi D; Dennetta D; Ugolini M; Alessandroni P; Catalano V; Fedeli SL; Giordani P; Casadei V; Baldelli AM; Graziano F; Catalano G
    Clin Lung Cancer; 2008 Sep; 9(5):280-4. PubMed ID: 18824450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel: a phase II study.
    Stathopoulos GP; Christodoulou Ch; Stathopoulos J; Skarlos D; Rigatos SK; Giannakakis T; Armenaki O; Antoniou D; Athanasiadis A; Giamboudakis P; Dimitroulis J; Georgatou N; Katis K
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):796-800. PubMed ID: 16142488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study.
    Pignata S; Breda E; Scambia G; Pisano C; Zagonel V; Lorusso D; Greggi S; De Vivo R; Ferrandina G; Gallo C; Perrone F
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):229-36. PubMed ID: 18243011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
    Davies AM; Chansky K; Lau DH; Leigh BR; Gaspar LE; Weiss GR; Wozniak AJ; Crowley JJ; Gandara DR;
    J Clin Oncol; 2006 Nov; 24(33):5242-6. PubMed ID: 17114656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of weekly administration of paclitaxel for advanced and metastatic gastric cancer].
    Emoto T; Yoshikawa K; Fujii M; Nezu R; Dousei T; Fujikawa M; Yoshioka Y; Naka Y; Komaki T
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):809-15. PubMed ID: 12852348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group.
    Grozea PN; Crowley JJ; Canfield VA; Kingsbury L; Ross SW; Beltran GS; Laufman LR; Weiss GR; Livingston RB
    Cancer; 1997 Sep; 80(6):1029-33. PubMed ID: 9305702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.